Advertisement
Advertisement

MIRA

MIRA logo

Mira Pharmaceuticals Inc

1.05
USD
-0.01
-0.94%
Dec 23, 15:47 UTC -5
Closed
...

Mira Pharmaceuticals Inc Profile

About

MIRA Pharmaceuticals Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. MIRA Pharmaceuticals Inc. is based in Baltimore, Maryland.

Info & Links

CEO

Erez Aminov

Headquarters

1200 BRICKELL AVENUE, SUITE 1950 #1183
MIAMI, FL 33131, UNITED STATES

Industry

Pharmaceuticals Other

Sector

Health Technology

Website

https://mirapharmaceuticals.com

Auditor

Cherry Bekaert LLP

Share holders

91

Employees

3

Mira Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

17.39M

Enterprise Value

13.24M

Enterprise Value/EBITDA(ttm)

-1.53

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.14

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-337.44%

Return on Invested Capital(ttm)

-320.13%

Return on Assets(ttm)

-280.58%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-8.64M

Net Income Available to Common(ttm)

-11.24M

Diluted EPS(ttm)

-0.56

Share Statistics

Beta (5Y Monthly)

1.93

52-Week Change

-70.83%

S&P 500 52-Week Change

25.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

16.56M

Dividend Yield

0.00%

Float4

15.46M

% Held by Insiders

6.65%

% Held by Institutions

35.16%

Balance Sheet

Total Cash(mrq)

4.14M

Total Cash Per Share(mrq)

0.25

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.11%

Quick Ratio(mrq)

6.11%

Book Value Per Share(mrq)

0.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.25

Free Cash Flow(ytd)

-3.76M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement